The most common side effects of Pristiq (desvenlafaxine) are nausea, dizziness, insomnia, excessive sweating, constipation, drowsiness, decreased appetite, and anxiety. In clinical trials, nausea was by far the most frequent, affecting about 22% of people taking the standard 50 mg dose compared to 10% on placebo. Most of these early side effects improve within the first one to two weeks of treatment.
The Most Frequent Side Effects
Pristiq works by boosting levels of two chemical messengers in the brain: serotonin and norepinephrine. That shift in brain chemistry treats depression, but it also affects the gut, the nervous system, and the sweat glands, which explains the pattern of side effects most people experience.
In pooled clinical trials using the standard 50 mg dose, the side effects that showed up most often were:
- Nausea: 22% (vs. 10% on placebo)
- Dizziness: 13% (vs. 5% on placebo)
- Excessive sweating: 10% (vs. 4% on placebo)
- Insomnia: 9% (vs. 6% on placebo)
- Constipation: 9% (vs. 4% on placebo)
- Fatigue: 7% (vs. 4% on placebo)
- Dry mouth: 11% (vs. 9% on placebo)
- Decreased appetite: 5% (vs. 2% on placebo)
Nausea is the side effect people notice first, and it tends to be the main reason people feel discouraged early on. The good news is that it typically fades within the first week or two as your body adjusts. The same is true for dizziness, fatigue, and trouble sleeping. Excessive sweating and dry mouth, on the other hand, can be more persistent for some people.
Higher Doses Mean More Side Effects
Pristiq is prescribed at 50 mg for most people, but some take 100 mg. Clinical trial data shows a clear pattern: nearly every side effect becomes more common at the higher dose. Nausea jumps from 22% at 50 mg to 26% at 100 mg. Dry mouth goes from 11% to 17%. Insomnia rises from 9% to 12%, and drowsiness more than doubles from 4% to 9%.
What makes this especially worth knowing is that clinical studies found no additional antidepressant benefit at doses above 50 mg. The higher doses produced more side effects and more people dropping out of trials, without better outcomes for depression. This is why 50 mg is the recommended starting and target dose.
Sexual Side Effects
Sexual side effects are common with Pristiq and often underreported because people feel uncomfortable bringing them up. In clinical trials, men were affected more noticeably than women. At the 50 mg dose, 4% of men reported decreased sex drive and 3% reported erectile dysfunction. At 100 mg, those numbers climbed to 5% and 6%, respectively. Delayed ejaculation affected about 1% of men at 50 mg but rose to 5% at 100 mg.
An observational study of people taking Pristiq in everyday clinical practice found that diminished sexual desire and erectile dysfunction each occurred in about 5.5% of men. Women reported orgasmic difficulties less frequently, at around 1.2%. These effects don’t typically fade on their own the way nausea does, so they’re worth discussing with your prescriber if they develop.
Weight Changes
Many people starting an antidepressant want to know whether it will cause weight gain. Pristiq is relatively neutral on this front. A post-hoc analysis combining data from nine studies found that people taking 50 mg or 100 mg daily experienced a small amount of weight loss (less than 1 kg, or about 2 pounds) during acute treatment. Over longer-term use, there was no significant weight change regardless of whether someone started at a normal weight, overweight, or obese. This makes Pristiq one of the more weight-neutral antidepressant options available.
Blood Pressure Effects
Because Pristiq increases norepinephrine activity, it can raise blood pressure in some people. In clinical trials, sustained high blood pressure occurred in about 1.3% of people on the 50 mg dose, compared to 0.5% on placebo. The effect is small at the standard dose but becomes more pronounced at higher doses, reaching 2.3% at 400 mg.
The increase is typically modest, but it matters if you already have high blood pressure or cardiovascular risk factors. Regular blood pressure monitoring is recommended before starting Pristiq and periodically during treatment.
Serotonin Syndrome
Serotonin syndrome is a rare but serious reaction that can happen when too much serotonin builds up in the body. The risk is highest when Pristiq is combined with other medications that also increase serotonin, such as certain migraine drugs, other antidepressants, or the supplement St. John’s wort.
Symptoms develop quickly and can include agitation, confusion, rapid heartbeat, unstable blood pressure, high body temperature, muscle twitching or rigidity, and gastrointestinal distress like nausea and diarrhea. In severe cases, it can become life-threatening. If you experience a sudden cluster of these symptoms, especially after starting Pristiq or adding a new medication, seek emergency care.
Suicidal Thinking in Young Adults
Pristiq carries an FDA boxed warning about an increased risk of suicidal thoughts and behavior in children, adolescents, and young adults under 25. This risk was identified across short-term studies of antidepressants as a class, not just Pristiq specifically. Adults over 24 did not show this increased risk in studies, and adults 65 and older actually showed a reduced risk compared to placebo. Close monitoring during the first several weeks of treatment is standard practice, particularly for younger patients.
What the First Few Weeks Look Like
Starting Pristiq typically means dealing with some combination of nausea, dizziness, and sleep disruption for the first one to two weeks. For most people, these early side effects settle down as the body adjusts. Taking the medication with food can help with nausea. Sweating and dry mouth may take longer to resolve or may persist throughout treatment. Sexual side effects, if they appear, also tend to be ongoing rather than temporary.
The antidepressant benefits of Pristiq usually take two to four weeks to become noticeable, which means there’s an awkward window where you’re experiencing side effects before the medication has fully kicked in. Knowing that the early discomfort is temporary for most people can make that waiting period easier to get through.